Research – Page 10

← Back to all research

peptide clinical research

Peptide PK/PD Translation: Connecting Concentration to Effect

Evidence quality depends on a defined question, transparent method, and explicit transfer boundary.

Evidence-led research on peptide pk/pd translation: connecting concentration to effect.

7 min read2026-08-13

peptide drug discovery

Peptide Receptor Selectivity Profiling: Evidence Across Binding and Function

Evidence quality depends on a defined question, transparent method, and explicit transfer boundary.

Evidence-led research on peptide receptor selectivity profiling: evidence across binding and function.

8 min read2026-08-13

peptide clinical research

Peptide Research Sample Integrity: Pre-Analytical Variables That Change Results

Evidence quality depends on a defined question, transparent method, and explicit transfer boundary.

Evidence-led research on peptide research sample integrity: pre-analytical variables that change results.

8 min read2026-08-13

peptide manufacturing

Peptide Sterile Filtration: Recovery, Adsorption, and Integrity Evidence

Evidence quality depends on a defined question, transparent method, and explicit transfer boundary.

Evidence-led research on peptide sterile filtration: recovery, adsorption, and integrity evidence.

7 min read2026-08-13

peptide analytics

Peptide Assay Transfer: Readiness, Comparability, and Documentation

Peptide assay transfer is a controlled comparison of method, materials, analysts, instruments, and acceptance criteria.

A research operations guide for transferring peptide analytical or bioassay methods between teams and laboratories.

2 min read2026-08-11

peptide drug delivery

Peptide Brain-Barrier Transport: What the Measurements Show

In a 2019 in-situ mouse perfusion study, Gly-Sar transport was 7.60 ± 1.29 µL/g·min at 200 µM (n=4).

Evidence-led review of peptide transport and barrier modulation findings for CNS research organizations.

3 min read2026-08-11

peptide stability

Peptide Cold-Chain Stability and Shipping: Research Operations Guide

Peptide shipping control joins stability-indicating evidence with packaging, temperature history, and excursion decisions.

How peptide teams can connect stability evidence, packaging, shipping excursions, and sample accountability.

3 min read2026-08-11

peptide formulation

Peptide Formulation Buffer Screening: Evidence and Decision Records

Peptide buffer screening compares pH, excipients, concentration, container, stress, and stability evidence as one system.

A research workflow for peptide buffer, excipient, pH, concentration, and stability screening.

2 min read2026-08-11

peptide analytics

Peptide Impurity Profiling: Research and Quality Evidence

Peptide impurity profiling joins process history, analytical specificity, identification, and quality review.

How peptide teams can organize impurity identification, analytical follow-up, and development decisions.

2 min read2026-08-11

peptide clinical research

Intact Peptide Bioanalysis and Exposure: Research Evidence 2026

ICH M10 separates accuracy, precision, selectivity, stability, and incurred-sample reproducibility as distinct bioanalytical evidence.

Measured evidence on intact-peptide assays, sampling, and exposure interpretation for peptide research teams.

3 min read2026-08-11

peptide formulation

Lyophilized Peptide Formulations: Stability Findings and Limits

A CSP7 peptide formulation retained more than 95% in solution at 5 and 25 °C for 48 hours and remained stable for up to 10 months at 5 °C when protected from moisture.

Measured stability findings for lyophilized peptide formulations, with implications for research coordination and evidence review.

3 min read2026-08-11

peptide drug discovery

Macrocyclic Peptide Permeability: Evidence for Discovery Teams

CycPeptMPDB assembled experimentally measured permeability data for 7,334 cyclic peptides from 45 papers and 2 company patents.

Measured permeability findings and development limits for macrocyclic peptide discovery programs.

3 min read2026-08-11